BCPC Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
49 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 32.57
- PEG ratio
- 3.62
- P/B
- 4.43
- P/S (TTM)
- 5.32
- EV/EBITDA
- 21.85
Profitability & growth
- ROE (TTM)
- 12.8%
- Operating margin
- 20.8%
- Revenue growth YoY
- 11.2%
- Dividend yield
- 0.5%
- Beta
- 0.81
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Balchem Corporation
Company profileBalchem Corporation develops, manufactures, and markets specialty ingredients and performance products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. The company is headquartered in New Hampton, New York.
Classification
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 5 PARAGON DRIVE, MONTVALE, NJ
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
